| European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update M Babjuk, M Burger, EM Compérat, P Gontero, AH Mostafid, J Palou, ... European urology 76 (5), 639-657, 2019 | 1863* | 2019 |
| European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update M Rouprêt, M Babjuk, E Compérat, R Zigeuner, RJ Sylvester, M Burger, ... European urology 73 (1), 111-122, 2018 | 1528 | 2018 |
| Prognostic performance and reproducibility of the 1973 and 2004/2016 World Health Organization grading classification systems in non–muscle-invasive bladder cancer: a European … V Soukup, O Čapoun, D Cohen, V Hernandez, M Babjuk, M Burger, ... European urology 72 (5), 801-813, 2017 | 268 | 2017 |
| Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non–muscle-invasive bladder cancer: review of the evidence and recommendations JA Witjes, JP Redorta, D Jacqmin, F Sofras, PU Malmström, C Riedl, ... European urology 57 (4), 607-614, 2010 | 194 | 2010 |
| European Association of Urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification … RJ Sylvester, O Rodríguez, V Hernández, D Turturica, L Bauerová, ... European urology 79 (4), 480-488, 2021 | 187 | 2021 |
| Grading of urothelial carcinoma and the new “World Health Organisation classification of tumours of the urinary system and male genital organs 2016” EM Compérat, M Burger, P Gontero, AH Mostafid, J Palou, M Rouprêt, ... European urology focus 5 (3), 457-466, 2019 | 182 | 2019 |
| Planning percutaneous nephrolithotomy using multidetector computed tomography urography, multiplanar reconstruction and three‐dimensional reformatting N Thiruchelvam, H Mostafid, G Ubhayakar BJU international 95 (9), 1280-1284, 2005 | 179 | 2005 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 166 | 2020 |
| Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita JYC Teoh, J Huang, WYK Ko, V Lok, P Choi, CF Ng, S Sengupta, ... European urology 78 (6), 893-906, 2020 | 151 | 2020 |
| Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European Association of Urology … B Peyronnet, T Seisen, JL Dominguez-Escrig, HM Bruins, CY Yuan, ... European urology focus 5 (2), 205-223, 2019 | 136 | 2019 |
| Radiofrequency-induced thermo-chemotherapy effect versus a second course of bacillus Calmette-Guérin or institutional standard in patients with recurrence of non–muscle … WS Tan, A Panchal, L Buckley, AJ Devall, LS Loubière, AM Pope, ... European urology 75 (1), 63-71, 2019 | 124 | 2019 |
| EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) M Babjuk, M Burger, E Compérat, P Gontero, AH Mostafid, J Palou, ... Eur Urol 71 (3), 447-61, 2017 | 119 | 2017 |
| Quality improvement in multidisciplinary cancer teams: an investigation of teamwork and clinical decision-making and cross-validation of assessments BW Lamb, N Sevdalis, H Mostafid, C Vincent, JSA Green Annals of surgical oncology 18, 3535-3543, 2011 | 114 | 2011 |
| Guideline of guidelines: asymptomatic microscopic haematuria BJ Linder, EJ Bass, H Mostafid, SA Boorjian BJU international 121 (2), 176-183, 2018 | 108 | 2018 |
| An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round Delphi survey, and a consensus meeting JYC Teoh, S MacLennan, VWS Chan, J Miki, HY Lee, E Chiong, LS Lee, ... European urology 78 (4), 546-569, 2020 | 107 | 2020 |
| Risk stratification tools and prognostic models in non–muscle-invasive bladder cancer: a critical assessment from the European Association of Urology Non-muscle-invasive … V Soukup, O Čapoun, D Cohen, V Hernández, M Burger, E Compérat, ... European urology focus 6 (3), 479-489, 2020 | 98 | 2020 |
| Phase I trial of an ICAM-1-targeted immunotherapeutic-coxsackievirus A21 (CVA21) as an oncolytic agent against non muscle-invasive bladder cancer NE Annels, D Mansfield, M Arif, C Ballesteros-Merino, GR Simpson, ... Clinical Cancer Research 25 (19), 5818-5831, 2019 | 97 | 2019 |
| Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European Association of Urology … JL Dominguez-Escrig, B Peyronnet, T Seisen, HM Bruins, CY Yuan, ... European urology focus 5 (2), 224-241, 2019 | 96 | 2019 |
| Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients WS Tan, A Feber, R Sarpong, P Khetrapal, S Rodney, R Jalil, H Mostafid, ... European urology 74 (1), 10-14, 2018 | 95 | 2018 |
| Epidemiology, screening, and prevention of bladder cancer N Lobo, L Afferi, M Moschini, H Mostafid, S Porten, SP Psutka, S Gupta, ... European urology oncology 5 (6), 628-639, 2022 | 90 | 2022 |
